Horizon Kinetics - SYNTA PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
Horizon Kinetics ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$5,000
+25.0%
18,0000.0%0.00%
Q1 2016$4,000
-33.3%
18,0000.0%0.00%
Q4 2015$6,000
-80.6%
18,0000.0%0.00%
-100.0%
Q3 2015$31,000
-13.9%
18,000
+12.5%
0.00%0.0%
Q2 2015$36,000
+16.1%
16,0000.0%0.00%
Q1 2015$31,000
+6.9%
16,000
+45.5%
0.00%
Q4 2014$29,000
-12.1%
11,0000.0%0.00%
Q3 2014$33,000
-26.7%
11,0000.0%0.00%
-100.0%
Q2 2014$45,000
-4.3%
11,0000.0%0.00%0.0%
Q1 2014$47,00011,0000.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 30,197,945$80,025,00092.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 457,458$1,212,0000.22%
Verity Asset Management, Inc. 82,383$218,0000.21%
STONERIDGE INVESTMENT PARTNERS LLC 332,238$880,0000.12%
Cutler Capital Management, LLC 62,500$165,0000.07%
Capital Impact Advisors, LLC 37,788$100,0000.05%
SECOR Capital Advisors, LP 35,087$93,0000.04%
STRATEGIC INVESTMENT MANAGEMENT, LLC 50,814$134,0000.04%
BOLTON LP 37,700$100,0000.03%
BOLTON LP 37,700$100,0000.03%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders